当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析 - 现金流量表

盟科药业-U

(688373)

  

流通市值:36.88亿  总市值:36.88亿
流通股本:6.56亿   总股本:6.56亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金97,719,938.2850,876,476.65154,244,657.8110,478,494.55
  收到的税费返还8,036,230.42---
  收到其他与经营活动有关的现金3,965,562.0811,434,630.588,394,563.947,228,482.7
  经营活动现金流入小计109,721,730.7862,311,107.23162,639,221.74117,706,977.25
  购买商品、接受劳务支付的现金81,211,445.4955,252,767.83246,327,825.83182,874,873.43
  支付给职工以及为职工支付的现金47,731,145.7821,183,794.13103,141,966.3179,617,413.48
  支付的各项税费2,905,486.421,130,337.9712,223,397.8510,972,264.65
  支付其他与经营活动有关的现金4,266,541.9757,692.3311,124,173.159,870,452.55
  经营活动现金流出小计136,114,619.5978,324,592.26372,817,363.14283,335,004.11
  经营活动产生的现金流量净额-26,392,888.81-16,013,485.03-210,178,141.4-165,628,026.86
二、投资活动产生的现金流量:
  收回投资收到的现金1,368,579,087.24687,190,055.612,662,132,824.031,925,256,071.61
  取得投资收益收到的现金3,273,397.31,327,289.046,780,551.715,350,663.78
  处置固定资产、无形资产和其他长期资产收回的现金净额--3,789.513,789.51
  投资活动现金流入小计1,371,852,484.54688,517,344.652,668,917,165.251,930,610,524.9
  购建固定资产、无形资产和其他长期资产支付的现金91,630.124,863.2549,086.98631,741.98
  投资支付的现金1,348,345,705.13666,090,894.812,502,876,863.491,753,093,752.88
  投资活动现金流出小计1,348,437,335.23666,115,758.012,503,425,950.471,753,725,494.86
  投资活动产生的现金流量净额23,415,149.3122,401,586.64165,491,214.78176,885,030.04
三、筹资活动产生的现金流量:
  吸收投资收到的现金--3,114,445-
  取得借款收到的现金20,050,000-205,702,238.6991,702,238.69
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计20,050,000-208,816,683.6991,702,238.69
  偿还债务支付的现金41,635,111.9610,313,974.55116,455,111.9619,743,974.55
  分配股利、利润或偿付利息支付的现金4,653,752.833,341,493.238,875,080.256,517,474.1
  支付其他与筹资活动有关的现金3,073,254.36202,797.7315,175,944.6111,389,209.9
  筹资活动现金流出小计49,362,119.1513,858,265.51140,506,136.8237,650,658.55
  筹资活动产生的现金流量净额-29,312,119.15-13,858,265.5168,310,546.8754,051,580.14
四、汇率变动对现金及现金等价物的影响-899,731.11-347,221.67-2,020,749.46-1,608,325.68
五、现金及现金等价物净增加额-33,189,589.76-7,817,385.5721,602,870.7963,700,257.64
  加:期初现金及现金等价物余额294,935,161.41294,935,161.41273,332,290.62273,332,290.62
  期末现金及现金等价物余额261,745,571.65287,117,775.84294,935,161.41337,032,548.26
补充资料:
  净利润-37,566,012.58--241,612,359.49-
  固定资产和投资性房地产折旧1,092,344.57-2,337,672.61-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,092,344.57-2,337,672.61-
  无形资产摊销292,540.92-733,087.06-
  长期待摊费用摊销1,528,164.66-3,056,906.28-
  处置固定资产、无形资产和其他长期资产的损失---1,496.97-
  公允价值变动损失-2,375,172.59--6,490,192.45-
  财务费用4,185,097.05-12,686,689.18-
  递延所得税-1,138,807.08---
  其中:递延所得税资产减少-1,142,474.29---
    递延所得税负债增加3,667.21---
  存货的减少4,212,997.28-2,683,587.83-
  经营性应收项目的减少6,893,961.61--27,256,175.3-
  经营性应付项目的增加-11,049,270.85-17,055,425.09-
  不涉及现金收支的投资和筹资活动金额其他项目4,265,258.51-325,782.09-
  现金的期末余额261,745,571.65-294,935,161.41-
  减:现金的期初余额294,935,161.41-273,332,290.62-
  现金及现金等价物的净增加额-33,189,589.76-21,602,870.79-
公告日期2026-08-262026-04-292026-03-282025-10-28
审计意见(境内)标准无保留意见
TOP↑